CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Technology Officer sold 33,750 shares at an average $2.44 ($82,388)
- 4 Derivatives Options or other derivatives
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Open-market sale Chief Commercial Officer sold 20,000 shares at an average $1.08 ($21,685)
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Commercial Officer sold 8,731 shares at $0.94 ($8,207)
- 4 Open-market sale Director sold 10,000 shares at $0.90 ($9,000)
Page 14 of 28 · 547 filings